Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) to be Presented at the National Kidney Foundation Spring Clinical Meetings
Provided By GlobeNewswire
Last update: Apr 10, 2025
WALTHAM, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that the company will present a post-hoc analysis of the OPTIMIZE Study, an open-label clinical trial of XPHOZAH ® (tenapanor), as a poster at the National Kidney Foundation (NKF) Spring Clinical Meetings, now underway in Boston. Ardelyx is also hosting an Exhibitor Showcase discussing hyperphosphatemia management.
Read more at globenewswire.com4.13
-1.34 (-24.5%)
Find more stocks in the Stock Screener
ARDX Latest News and Analysis
3 days ago - ChartmillWhich stocks are moving on Friday?Intrigued by the market activity one hour before the close of the markets on Friday? Uncover the key winners and losers of today's session in our insightful analysis.
3 days ago - ChartmillHere are the top movers in Friday's session.Curious to know what's happening on the US markets in the middle of the day on Friday? Join us as we explore the top gainers and losers in today's session.
3 days ago - ChartmillWhich stocks are gapping on Friday?There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Friday.
3 days ago - ChartmillWhat's going on in today's pre-market sessionThe US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
4 days ago - ChartmillGet insights into the top gainers and losers of Thursday's after-hours session.Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.
